Form 8-K - Current report:
SEC Accession No. 0001079973-25-000446
Filing Date
2025-03-24
Accepted
2025-03-24 07:00:08
Documents
16
Period of Report
2025-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K toi_8k.htm   iXBRL 8-K 28882
2 PRESS RELEASE ex99x1.htm EX-99.1 176840
3 GRAPHIC image_001.gif GRAPHIC 3013
  Complete submission text file 0001079973-25-000446.txt   453247

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE toi-20250324.xsd EX-101.SCH 3911
5 XBRL DEFINITION FILE toi-20250324_def.xml EX-101.DEF 26803
6 XBRL LABEL FILE toi-20250324_lab.xml EX-101.LAB 37032
7 XBRL PRESENTATION FILE toi-20250324_pre.xml EX-101.PRE 25427
18 EXTRACTED XBRL INSTANCE DOCUMENT toi_8k_htm.xml XML 6174
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 25762188
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)